Technavio analyzes that the Hyperthermia Cancer Treatment Market is expected to grow at a CAGR of 5.9% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 59 million.There are various factors that contribute to the growth of the market. The Hyperthermia Cancer Treatment Market is witnessing significant growth due to escalating research and development investments. This sector is experiencing a surge in interest from pharmaceutical companies and research institutions, driven by the potential of hyperthermia to enhance the efficacy of conventional cancer therapies. The market's expansion is further fueled by advancements in technology, enabling more precise and effective hyperthermia treatments. These developments are poised to revolutionize cancer care and offer new hope to patients.
The global hyperthermia cancer treatment market witnesses significant growth, driven by the increasing adoption of non-invasive therapies in hospitals and specialty clinics. With initiatives like Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in India, access to advanced medical treatments, including hyperthermia, is expanding. As of January 2024, over 27,000 hospitals and clinics, including 11,973 private institutions, have been empaneled under AB-PMJAY. These facilities offer radiation dose weighting technologies, such as radiofrequency (RF), microwave, brachytherapy, and internal heating, for hyperthermia treatments. Telemedicine resources are also being integrated to enhance the delivery of care. Clinical trials continue to explore the potential of hyperthermia in tumor treatment, further fueling market expansion.
Know which region is leading the market growth by requesting a sample report
Hyperthermia Cancer Treatment Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
The Hyperthermia Cancer Treatment Market encompasses innovative solutions for cancer patients with low immunity, including telemedicine and digital platforms for enhanced patient care. Glass ceramics with bioactivity and osteoproductivity are utilized in Hyperthermia, a type of cancer treatment. Microwave, ultrasound, and infrared devices are used for local and whole-body hyperthermia, complementing radiation, chemotherapy, gene therapy, and minimally/non-invasive treatments. Conditions like Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, and Prostate Cancer are targeted with various Hyperthermia devices, including Microwave, Ultrasound, Infrared, and Shortwave devices, in cancer management.
In the healthcare sector, the hyperthermia cancer treatment market holds significant potential for growth. This market caters to cancer patients with low immunity, utilizing advanced technologies such as telemedicine and digital platforms for enhanced patient care. Key players in this market include manufacturers and providers of hyperthermia equipment, glass ceramics, and bioactivity solutions. The global pharmaceuticals market, which encompasses the revenue generated by entities involved in R&D, production, and distribution of pharmaceuticals, biotechnology, and life sciences tools and services, is expected to expand substantially. Factors driving this growth include an aging population, with Europe and the US forecasted to have over 25% of their populations aged 60 and above by 2030 and 2050, respectively.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
